Answer and Critique (Correct Answer = D)
Although this patient's statement regarding her fear of needles is important, it is equally important to ascertain the exact nature of her fear in order to respond appropriately. Often...
|
Letter from the Editor #487
|
All week long we've heard politicians, lobbyists and radio personalities weigh in with their opinions on a national health care system. It seems like the public option idea is what is driving the most discussions and debate. It also seems to...
|
Quote #487
|
"There is nothing either good or bad, but thinking makes it so."
………………….William Shakespeare
|
Miscellaneous Front Page #487
|
New Product: Valturna
Valturna (the combination of the renin inhibitors valsartan and aliskiren): for treatment of high...
|
Test Your Knowledge #487
|
A 62-year-old recently retired female school teacher who was diagnosed with Type 2 diabetes 18 years ago comes for a routine evaluation. Her medications include maximum dosages of rosiglitazone, metformin, and repaglinide. She tells you she...
|
More Money Spent on Diabetes Meds than on Any Other Condition
|
More Money Spent on Diabetes Meds than on Any Other Condition: The Diabetes UK Center claimed that the increase was being pushed up by younger people developing Type 2 diabetes and being prescribed insulin to manage their...
|
B12 Deficiency in Diabetes
|
B12 Deficiency in Diabetes: Although metformin use and advanced age are associated with vitamin B12 deficiency and often present in Type 2 diabetic patients, the prevalence of vitamin B12 deficiency in the diabetic...
|
Thirty percent of US public have hypertension, much of which is due to excessive sodium intake
|
Thirty percent of US public have hypertension, much of which is due to excessive sodium intake. One of the first studies to estimate the economic benefits of lowering sodium consumption among the US public has found that...
|
Weight Loss is Good for the Kidneys
|
Weight Loss is Good for the Kidneys: Losing weight may preserve kidney function in obese people with...
|
Update on Dr. Faustman's Research on Reversing Type 1 Diabetes
|
The Faustman Lab at Massachusetts General Hospital, run by Denise L. Faustman, MD, PhD, is moving rapidly through the clinical trial challenge to test and possibly establish a vaccine using a generic drug, Bacillus Calmette-Guérin...
|
New Program Offers Community Pharmacies an Expanded Role in Diabetes Self-Management Training + Provides Hours to Become a CDE
|
The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be...
|
Early Triple Therapy for Type 2 Diabetes
|
When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.
|
Diabetic Retinopathy Linked to Inflammatory Markers
|
In patients with Type 1 diabetes and kidney disease, several serum markers of inflammation and endothelial dysfunction are associated with increasing prevalence and severity of diabetic retinopathy, investigators report.
|
WHR Is a Better Predictor of All-Cause Mortality in Older Adults than BMI
|
Waist-to-hip circumference ratio (WHR) may be a better predictor of all-cause mortality in older adults versus body mass index (BMI), according to the results of a study.
|
Bariatric Surgical in Moms Improves Cardio-Metabolic Markers in Kids
|
Weight loss after bariatric surgery in mothers is associated with improvements in cardio-metabolic markers in their offspring that are sustained into adolescence, according to a published paper.
|
Increased Spending Buys Better Diabetes Outcomes
|
For patients with Type 2 diabetes, increased health care spending on risk factor control seems to be paying off, according to results of an economic analysis just released.
|
Lorcaserin Meets Primary Endpoints in Second Obesity Trial
|
Arena Pharmaceuticals, Inc., said last Friday its obesity drug candidate Lorcaserin met primary efficacy and safety endpoints in the second late-stage trial, dubbed BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity...
|
Sixty-three percent of Physicians Favor Public Option
|
A solid majority of physicians favor creating a new public insurance option that would operate alongside existing private plans, according to a survey published online in The New England Journal of Medicine.
|
| | | | | | | | | | | | | | | |